Pigmented purpuric dermatosis - Classification by phenotypic and molecular profiles

被引:42
作者
Magro, Cynthia M.
Schaefer, Jochen T.
Crowson, A. Neil
Li, Jingwei
Morrison, Carl
机构
[1] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York Presbyterian Hosp, New York, NY 10021 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Oklahoma, Tulsa, OK USA
[4] Reg Med Labs, Tulsa, OK USA
[5] Ohio State Univ, Columbus, OH 43210 USA
关键词
pigmented purpuric dermatosis; cutaneous lymphoid dyscrasia;
D O I
10.1309/AQMU3JFE2A66LC7E
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The categorization of pigmented purpuric dermatosis (PPD) as a form of cutaneous lymphoid dyscrasia has been suggested. Phenotypic and molecular studies were done on 43 patients with PPD. The molecular studies used a capillary gel electrophoresis T-cell receptor beta multiplex polymerase chain reaction assay. There were 2 principal categories: polyclonal PPD represented by 22 cases and monoclonal variants comprising 21 cases. Monoclonal cases had extensive skin lesions. An identical restricted T-cell repertoire independent of time and location was observed. Approximately 40% of the monoclonal cases had clinical and pathologic features of mycosis fungoides (MF). In the polyclonal variant, disease outside the lower extremities was uncommon; there were no patients with MF Striking reductions in CD7 and CD62L were seen in both groups. PPD is a form of cutaneous T-cell lymphoid dyscrasia, based on the frequency of monoclonality, the preservation of persistent T-cell clonotypes, and extent of pan-T-cell marker loss. Stratification of lesions of PPD according to the molecular profile may be of significant value prognostically and influence therapeutic intervention.
引用
收藏
页码:218 / 229
页数:12
相关论文
共 23 条
[1]   PROGRESSION OF PIGMENTED PURPURA-LIKE ERUPTIONS TO MYCOSIS-FUNGOIDES - REPORT OF 3 CASES [J].
BARNHILL, RL ;
BRAVERMAN, IM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 19 (01) :25-31
[2]   Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy:: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response [J].
Breza, Thomas S., Jr. ;
Zheng, Pan ;
Porcu, Pierluigi ;
Magro, Cynthia M. .
JOURNAL OF CUTANEOUS PATHOLOGY, 2006, 33 (07) :522-528
[3]   Assessment of T-cell clonality via T-cell receptor-γ rearrangements in cutaneous T-cell-dominant infiltrates using polymerase chain reaction and single-stranded DNA conformational polymorphism assay [J].
Chen, M ;
Deng, A ;
Crowson, AN ;
Srinivasan, M ;
Yearsley, KH ;
Jewell, S ;
Morrison, C ;
Long, S ;
Werling, R ;
Magro, C .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2004, 12 (04) :373-379
[4]   Atypical pigmentary purpura: A clinical, histopathologic, and genotypic study [J].
Crowson, AN ;
Magro, CM ;
Zahorchak, R .
HUMAN PATHOLOGY, 1999, 30 (09) :1004-1012
[5]   Persistent pigmented purpuric eruption associated with mycosis fungoides: a case report and review of the literature [J].
Georgala, S ;
Katoulis, AC ;
Symeonidou, S ;
Georgala, C ;
Vayopoulos, G .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2001, 15 (01) :62-64
[6]  
Hale Elizabeth K, 2003, Dermatol Online J, V9, P17
[7]   Mycosis fungoides presenting as pigmented purpuric dermatitis [J].
Hanna, Shannon ;
Walsh, Noreen ;
D'Intino, Yolanda ;
Langley, Richard G. B. .
PEDIATRIC DERMATOLOGY, 2006, 23 (04) :350-354
[8]   PIGMENTED PURPURIC ERUPTION IN A PATIENT WITH RHEUMATOID-ARTHRITIS [J].
JORIZZO, JL ;
GONZALEZ, EB ;
APISARNTHANARAX, P ;
DANIELS, JC .
ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (12) :2184-2185
[9]   Pigmented purpura over the lower extremities [J].
Kim, HJ ;
Skidmore, RA ;
Woosley, JT .
ARCHIVES OF DERMATOLOGY, 1998, 134 (11) :1477-+
[10]   Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas [J].
Klemke, C-D ;
Fritzsching, B. ;
Franz, B. ;
Kleinmann, E. V. ;
Oberle, N. ;
Poenitz, N. ;
Sykora, J. ;
Banham, A. H. ;
Roncador, G. ;
Kuhn, A. ;
Goerdt, S. ;
Krammer, P. H. ;
Suri-Payer, E. .
LEUKEMIA, 2006, 20 (06) :1123-1129